인공심장판막치환술의 임상적 고찰

Clinical Review of Prosthetic Heart Valve Replacement

  • 장기경 (메리놀병원 흉부외과) ;
  • 윤후식 (메리놀병원 흉부외과, 메리놀병원 흉부외과, 방지거병원 흉부외과, 연세대학교 심장혈과외과, 연세대학교 의과대학 심혈관연구소)
  • 발행 : 1996.09.01

초록

1989년 9월부터 1995년 5월까지 메리놀병원 흉부외과에서는 107례의 환자에서 인공심장판막치환술을 시행하였다. 환자의 연령분포는 19세부터 75세까지 였으며 평균 42.6$\pm$11.7세였고, 남녀비는 33:74였다. 승모판막치환술이 61례(57%)로 가장 많았으며, 중복판막치 환술 28례(26.2%), 대동맥 판막치 환술 18례 (16.8%)였다. 전체 사망율은 14.9%(16명)였으며, 조기사망율은 5.6%(6명), 만기 사망율은 9.3%(10명)이었다. 생존율은 술후 2년에 92.6$\pm$2.6 %, 술후 6년에 88.6$\pm$3.8%였다. 판막실패없는 빈도는 술후 6년에 88.6$\pm$3.8, 혈전전색증없는 빈도는 술후 6년에 88.3$\pm$3.9, 심내막염없는 빈도는 술후 6년에 89.5$\pm$ 3.7를 나타냈다.

Cardiac valve implantation was performed in 107 patients from September, 1988 to May, 1995. There were 3) men and 74 women, whose ages ranged from 19 to 75 years(mean 42.6$\pm$11.7). Mitral valve was implanted in 61 patients, double(mitral & aortic) valve were Implanted in 28 patients and aortic valve was implanted in 18 patients. Follow up was 100% complete, with 345.6 patient-years and a mean fo low up of 41 months(from 1.5 to 84 months). The total mortality was 14.9%(16 patients). The early mortality was 5.6%(6 patients) and the late mortality was 9.3%(10 patients). The overall actuarial survival was 92.6 $\pm$ 2 6% at 2 years, 88.6$\pm$3.8% at 6 years. The probability of freedom from valve failure, thromboembolism and bacterial endocarditis were 388.6 $\pm$ 3.8, 88.3 $\pm$3.9, 89.5 $\pm$3.7 at 6 years, respectively.

키워드

참고문헌

  1. Ann Thorac Surg v.96 Guidelines for reporting morbidity and mortality after cardiac valvular operations Edmunds,L.H.;Clark,R.E.;Cohn,L.H.;Miller,C.;Weisel,R.D.
  2. Ann Thorac Surg v.24 Actuarial analysis of surgical results : rationale and method Grunkemeier,G.L.;Starr,A.
  3. Scand J Thorac Cardiovasc Surg v.5 Clinical and hemodynamic results of aortic valve replacement with the Bjork-Shiley tilting disc valve prosthesis Bjork,V.O.
  4. 대흉외지 v.27 심장판막치환술의 임상적 고찰 강창희;은종화;남충희;이길노
  5. 대흉외지 v.20 심장판막질환의 외과적 치료에 관한 임상적 고찰 박명규
  6. J Thorac Cardiovasc Surg v.47 Mitral valve replacement with preservation of papillary muscles and chordae tendinae Lillehei,C.W.;Levy,M.J.;Bonnabeau,R.C.
  7. Circulation v.68 no.Suppl 2 The importance of the mitral apparatus in left ventricular function after correction of the mitral regurgitation David,T.E.;Uden,D.E.;Strauss,H.D.
  8. Cardiol Clin v.3 Thromboembolic complications of prosthetic valves Addonizio,V.P.;Edmunds,L.H.
  9. 대흉외지 v.25 St. Jude medical 기계판막의 단기 및 중기성적 조범구;장병철;강면식;방정현;홍승록
  10. 대흉외지 v.22 Bjork-Shiley 기계판막의 임상적 연구 김병열;강경훈;이정호;유희성
  11. J Thorac Cardiovasc Surg v.87 The risk of thromboembolism and hemorrhage following mitral valve replacement Gonzalez-Lavin L.;Tandon,A.P.
  12. 대흉외지 v.25 쌍엽기계판막에 관한 임상연구 박계현;백완기;안혁;채헌;김종환
  13. 대흉외지 v.22 후천성 심질환의 인공판막 치환술에 대한 임상적 고찰 이준영;지행옥
  14. J Cardiovasc Surg(Torino) v.32 Bioprosthetic valve endocarditis:factors affecting bad outcome Gagliardi,C.;Di Tommaso L.;Mastroroberto,P.;Stassano,P.;Spampinato,N.